In the article entitled “Sympathetic Nerve Activity following Acute Type B Aortic Dissection: A Pilot Study” [J Vasc Res. 2024; DOI: 10.1159/000543340] by Lim et al., some individuals were incorrectly reported as having an MSNA burst incidence of >100 bursts per 100 beats.
The authors reviewed the original data and identified that the previously amended version to address this query initially raised during the peer review process was not included in the final submitted manuscript. The authors have reviewed the initial raw data and identified that the published MSNA burst incidence is incorrect and should not exceed 100 bursts per 100 beats. The authors have identified that the MSNA burst incidence in the acute phase was 97 bursts/100 beats (73–99) in the patient group compared to 71 bursts/100 beats (39–97) in the control group (effect size 0.83). In the recovery phase, the MSNA burst incidence in the patient group was 75 bursts/100 beats (50–91) compared to 62 bursts/100 beats (43–80) in the control group (effect size 0.50). This has been corrected and revisions are required to Figure 1 and Table 2 as well as values in the Results section of the abstract, and values in the Results section entitled Sympathetic Nerve Activity.
The original article has been updated to reflect these changes.
The publisher has archived the original publication version.
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
